+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Correlation between ST-T-Segment Changes with Markers of Hemostasis in Patients with Acute Coronary Syndromes


      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Background: Disturbance of the hemostatic and the inflammatory system plays an important role in the pathophysiology of acute coronary syndromes (ACS). Their markers have been shown to predict further coronary events in patients with ACS. The prognostic value of the admission electrocardiogram (ECG), which is commonly used to evaluate ischemia, was studied previously. We investigated the correlation between serum markers of the hemostatic/inflammatory system and ECG changes in ACS. Methods: A standard 12-lead ECG was obtained from 85 patients with ACS on admission (0d). Markers of the hemostatic and inflammatory system were measured on admission and after 2 days (2d). Results: Patients with ST-T-changes had higher fibrinogen and thrombin-antithrombin III complex (TAT) levels than patients without ECG alterations at both times (fibrinogen: 0d: 492 ± 38 vs. 357 ± 36 mg/dl, p < 0.01; 2d: 633 ± 55 vs. 440 ± 50 mg/dl, p < 0.02; TAT: 0d: 7.2 ± 1.3 vs. 3.6 ± 0.7 µg/l, p < 0.05; 2d: 5.3 ± 0.9 vs. 3.2 ± 0.5 µg/l, p < 0.05). Tissue-type plasminogen activator (TPA) was elevated in patients with ECG changes initially (10.1 ± 0.6 vs. 7.2 ± 0.7 ng/ml, p < 0.02). D-dimers, the acute-phase proteins C-reactive protein, serum amyloid A and the soluble adhesion molecules showed no significance. Conclusions: The data reveal a correlation between electrocardiographic changes and hemostasis in patients with ACS . The association of myocardial damage and a disturbed hemostatic system might stratify patients who are at high risk of suffering further coronary events.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.

          The prognosis of patients hospitalized with acute myocardial ischemia is quite variable. We examined the value of serum levels of cardiac troponin T, serum creatine kinase MB (CK-MB) levels, and electrocardiographic abnormalities for risk stratification in patients with acute myocardial ischemia. We studied 855 patients within 12 hours of the onset of symptoms. Cardiac troponin T levels, CK-MB levels, and electrocardiograms were analyzed in a blinded fashion at the core laboratory. We used logistic regression to assess the usefulness of baseline levels of cardiac troponin T and CK-MB and the electrocardiographic category assigned at admission-ST-segment elevation, ST-segment depression, T-wave inversion, or the presence of confounding factors that impair the detection of ischemia (bundle-branch block and paced rhythms)-in predicting outcome. On admission, 289 of 801 patients with base-line serum samples had elevated troponin T levels (> 0.1 ng per milliliter). Mortality within 30 days was significantly higher in these patients than in patients with lower levels of troponin T (11.8 percent vs. 3.9 percent, P < 0.001). The troponin T level was the variable most strongly related to 30-day mortality (chi-square = 21, P < 0.001), followed by the electrocardiographic category (chi-square = 14, P = 0.003) and the CK-MB level (chi-square = 11, P = 0.004). Troponin T levels remained significantly predictive of 30-day mortality in a model that contained the electrocardiographic categories and CK-MB levels (chi-square = 9.2, P = 0.027). The cardiac troponin T level is a powerful, independent risk marker in patients who present with acute myocardial ischemia. It allows further stratification of risk when combined with standard measures such as electrocardiography and the CK-MB level.
            • Record: found
            • Abstract: not found
            • Article: not found

            C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy

              • Record: found
              • Abstract: not found
              • Article: not found

              Endogenous tissue-type plasminogen activator and risk of myocardial infarction


                Author and article information

                S. Karger AG
                September 2002
                26 September 2002
                : 98
                : 1-2
                : 40-45
                aMedizinische Klinik, Abteilung III, and bKlinik für Anaesthesiologie und Intensivmedizin, Eberhard-Karls-Universität, Tübingen, cKlinik für Kardiologie und Allgemeine Innere Medizin, Städtisches Klinikum, Solingen, Germany
                64683 Cardiology 2002;98:40–45
                © 2002 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                : 21 January 2002
                : 09 May 2002
                Page count
                Figures: 3, Tables: 2, References: 28, Pages: 6
                General Cardiology

                General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
                Thrombin-antithrombin III,ECG,Fibrinogen,Acute coronary syndrome,Tissue-type plasminogen activator


                Comment on this article